Focused Ultrasound and Other Lesioning Therapies in Movement Disorders

AbstractPurpose of ReviewLesioning therapies have been some of the earliest, most effective surgical treatments in movement disorders. This review summarizes recent studies, emerging modalities, and trends in lesioning procedures for movement disorders.Recent FindingsMagnetic resonance –guided high-intensity focused ultrasound (MRgFUS) is the newest incisionless technology for lesioning procedures in movement disorders. It has recent FDA approval for thalamotomy in essential tremor and tremor-dominant Parkinson disease. There are current studies exploring subthalamotomy and pall idotomy in PD. Gamma knife is another incisionless modality that has been studied for decades and remains an effective treatment, albeit with less recent studies and more risks for adverse events, in movement disorders. Radiofrequency lesioning remains an efficacious treatment, particularly for unil ateral pallidotomy in PD, but has fallen out of favor compared with other modalities, particularly MRgFUS.SummaryLesioning therapies in movement disorders have shown efficacy in treating a variety of movement disorders. Enthusiasm for their use has waned with the advent of deep brain stimulation. The recent development of MRgFUS has recentered attention on lesioning therapy and its potential. Patient preference and access to care will remain determinants in the use of lesioning therapy as more data are being collected on the long-term benefit and safety.
Source: Current Neurology and Neuroscience Reports - Category: Neuroscience Source Type: research

Related Links:

Publication date: Available online 30 May 2020Source: NeuropsychologiaAuthor(s): Sonia Di Tella, Francesca Baglio, Laura Pelizzari, Monia Cabinio, Raffaello Nemni, Daniela Traficante, Maria Caterina Silveri
Source: Neuropsychologia - Category: Neurology Source Type: research
AbstractParkinson ’s disease (PD) was first formally described by James Parkinson in 1817, but the shaking of limbs was described in the literature of several ancient civilizations, such as ancient Chinese civilization and ancient Indian civilization. Historically, botanical drugs were used as the main source for t he treatment of such kind of disorders. In Western countries, plant extracts also occupied an important place in the earlier medications of PD. With the adventure of synthetic drugs, the role of plant-derived drugs in management of PD has been diminished. Nowadays, there is still no cure for PD, dop aminer...
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
Authors: Argyrou A Abstract Protein folding is considered strongly linked with genetics. The deeper understanding of the mechanisms that allow the folding of proteins is expected to lead to advances in the pharmaceutical sector. The shape of a protein dictates its biological activity, and any exceptions from its natural form can lead to diseases such as Alzheimer's, Parkinson's, and many others. The recent advances in the research of protein folding include computational models for the prediction of protein folding with enough accuracy. In order to understand the process of protein misfolding, a synopsis of the pro...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
Authors: Salis C, Papageorgiou L, Papakonstantinou E, Hagidimitriou M, Vlachakis D Abstract Neurodegenerative diseases lead to the death of nerve cells in the brain or the spinal cord. A wide range of diseases are included within the group of neurodegenerative disorders, with the most common ones being dementia, Alzheimer's, and Parkinson's diseases. Millions of older people are suffering from such pathologies. The global increase of life expectancy unavoidably leads to a consequent increase in the number of people who will be at some degree affected by neurodegenerative-related diseases. At this moment, there is n...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
In conclusion, quercetin possesses strong iron-chelating abilities and could be recommended as a disease-modifying therapy when administered in combination with L-dopa, early on in the course of Parkinson's disease. PMID: 32468451 [PubMed - in process]
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
ConclusionUnderstanding these common links and central topologies under the perspective of systems biology and network theory and greater insights are provided to uncover the complex neurodegeneration processes. PMID: 32468556 [PubMed - in process]
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
This article is about "kinesia paradoxa," a phenomenon presented in Parkinson's disease patients who generally suffer from bradykinesia and freezing of gait (FOG) but under certain circumstances exhibit a sudden, brief period of mobility. The objective of this paper was to identify the mechanisms causing this phenomenon, record possible brain circuits involved, and try to locate interconnections between these circuits. Moreover, we are proposing various modeling schemes in order to form the appropriate conditions for experimental design. PMID: 32468533 [PubMed - in process]
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
Lee James Mutations within the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are the most common genetic cause of autosomal and sporadic Parkinson’s disease (PD). LRRK2 is a large multidomain kinase that has reported interactions with several membrane proteins, including Rab and Endophilin, and has recently been proposed to function as a regulator of vesicular trafficking. It is unclear whether or how the spatiotemporal organization of the protein is altered due to LRRK2 activity. Therefore, we utilized fluctuation-based microscopy along with FLIM/FRET to examine the cellular properties and membrane recruitm...
Source: Molecules - Category: Chemistry Authors: Tags: Article Source Type: research
Authors: Shimada H, Shimada Y Abstract An 86-year-old man, who had undergone a lumboperitoneal shunt for idiopathic normal pressure hydrocephalus (iNPH) implanted 4 years earlier showed progressive parkinsonism for the past year. His clinical symptoms, including resting tremor and rapid eye movement sleep behavior disorder, responsiveness to levodopa, and abnormal findings on 123I-MIBG myocardial scintigraphy and dopamine transporter imaging, indicated that his pathological background of parkinsonism included concomitant synucleinopathy, such as Parkinson's disease or dementia with Lewy bodies, in addition to iNPH....
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
Publication date: Available online 29 May 2020Source: Neurología (English Edition)Author(s): F. Valldeoriola, F. Grandas, J.M. Arbelo, M. Blázquez Estrada, M. Calopa Garriga, V.M. Campos-Arillo, P.J. Garcia Ruiz, J.C. Gómez Esteban, C. Leiva Santana, J.C. Martínez Castrillo, P. Mir, A. Salvador Aliaga, F. Vivancos Matellano, R.M. Yáñez Baña
Source: Neurologia - Category: Neurology Source Type: research
More News: Brain | Deep Brain Stimulation | High Intensity Focused Ultrasound Therapy | Neurology | Neuroscience | Parkinson's Disease | Study | Ultrasound